“Flexibility is built into our DNA. The ability and dedication to solving our clients’ complex problems, no matter what it takes, is the key to our long-term relationships.” — Andrew Mitchell, Senior Director Business Development BIOVECTRA in Numbers 50+ Years of experience 100+ Active clie...
Process development, validation scale-up, and tech transfers Leverage our expertise in chemistry, manufacturing, and technology Commercial API drug manufacturing services Second-generation process development for continuous improvement Analytical services Trust our experts and state-of-the-...
Process development, validation scale-up, and tech transfers Leverage our expertise in chemistry, manufacturing, and technology Commercial API drug manufacturing services Second-generation process development for continuous improvement Analytical services Trust our experts and state-of-the-art labs...
In any clinical development, whether early or late phase, the first challenge is to ensure sufficient quantity of the drug substance (active pharmaceutical ingredient; API) to cover future clinical phases. However, a pre-clinical manufacturing process to make d...
BIOVECTRA is a Canadian contract drug manufacturer specializing in API drug development and biologics in Canadian based cGMP facilities.
that are used in FDA-regulated prescription and over-the-counter (OTC) drug products. The purpose of the QMM API Pilot Program is to gain insight from third-party assessments of a facility’s quality management system to inform future development...
Search PharmaCompass to Find Contract (CMO / CDMO) Services for API & Drug Product Development, API Development, Small Scale Batch
Managing accelerated timelines in manufacturing high-potency drugs. Highly potent API (HPAPI) drugs make up a growing percentage of the small molecule drug development pipeline and this group of products is growing faster than the overall small molecule segment,1largely due to their usefulness in ca...
The rise in the aging population is one of the primary drivers of thepharmaceutical API manufacturingmarket. As the aging population increases, the demand for pharmaceutical drugs also increases. API is a specialty drug in these medicines to cure a particular disease. Therefore, this in...
The impurities in drug substances mostly come from starting substrates, reagents, solvents, and side reactions of the synthetic route employed. Therefore, assessment and control of the undesired substances is an essential aspect of the drug development journey, with special consideration of patient healt...